This inventor holds 8 USPTO granted patents and 3 published patent applications and 2 EPO patents. Top assignee: Ono Pharmaceutical Co., Ltd.. Active years: 2006-2016.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Location History:
- Mishima-gun, JP (2006 - 2011)
- Osaka, JP (2013 - 2016)
Company Filing History:
Years Active: 2006-2016
Title: Yoshifumi Kagamiishi: Innovator in Functional Brain Disease Treatment
Introduction
Yoshifumi Kagamiishi is a prominent inventor based in Osaka, Japan. He has made significant contributions to the field of pharmaceuticals, particularly in the treatment of functional brain diseases. With a total of 8 patents to his name, Kagamiishi's work is recognized for its innovative approaches to complex medical issues.
Latest Patents
Kagamiishi's latest patents include a groundbreaking agent for preventing or treating functional brain diseases, specifically focusing on (2R)-2-propyloctanoic acid. This agent aims to inhibit the development of symptoms associated with various conditions such as depression, panic disorder, and post-traumatic stress disorder. Another notable patent involves a tricyclic compound that demonstrates anti-stress action, making it useful for treating stress-related digestive system diseases. These inventions highlight his commitment to improving patient outcomes through innovative solutions.
Career Highlights
Throughout his career, Kagamiishi has been associated with Ono Pharmaceutical Co., Ltd., where he has played a crucial role in advancing research and development in the pharmaceutical industry. His expertise and dedication have led to significant advancements in the treatment of mental health conditions.
Collaborations
Kagamiishi has collaborated with esteemed colleagues such as Hisao Nakai and Kazuyuki Ohmoto. These partnerships have fostered a collaborative environment that encourages innovation and the sharing of ideas, further enhancing the impact of their work in the field.
Conclusion
Yoshifumi Kagamiishi stands out as a key figure in the development of treatments for functional brain diseases. His innovative patents and collaborative efforts reflect his dedication to improving healthcare solutions. His contributions continue to pave the way for advancements in the pharmaceutical industry.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile